Alkermes PlcNASDAQ:ALKS
- LAST PRICE24.6800
- TODAY'S CHANGE (%)0.2400 (0.9820%)
- Bid / Lots24.0000/ 1
- Ask / Lots25.3600/ 1
- Open / Previous Close24.5500 / 24.4400
- Day Range
- 52 Week Range
- Volume1,016,741
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALKS |
|---|---|---|
| 09:32 ET | 4241 | 24.45 |
| 09:36 ET | 264 | 24.4 |
| 09:38 ET | 200 | 24.44 |
| 09:39 ET | 1200 | 24.42 |
| 09:41 ET | 500 | 24.46 |
| 09:43 ET | 2878 | 24.455 |
| 09:45 ET | 1577 | 24.465 |
| 09:48 ET | 400 | 24.44 |
| 09:50 ET | 2055 | 24.435 |
| 09:52 ET | 678 | 24.41 |
| 09:54 ET | 1245 | 24.44 |
| 09:56 ET | 1300 | 24.49 |
| 09:57 ET | 1596 | 24.5 |
| 09:59 ET | 1600 | 24.495 |
| 10:01 ET | 2989 | 24.49 |
| 10:03 ET | 2584 | 24.51 |
| 10:06 ET | 400 | 24.48 |
| 10:08 ET | 400 | 24.46 |
| 10:10 ET | 1000 | 24.415 |
| 10:12 ET | 1500 | 24.42 |
| 10:14 ET | 2064 | 24.385 |
| 10:15 ET | 700 | 24.37 |
| 10:17 ET | 100 | 24.37 |
| 10:19 ET | 1900 | 24.33 |
| 10:21 ET | 4929 | 24.325 |
| 10:24 ET | 1200 | 24.35 |
| 10:26 ET | 700 | 24.34 |
| 10:28 ET | 856 | 24.36 |
| 10:30 ET | 773 | 24.39 |
| 10:32 ET | 1074 | 24.43 |
| 10:33 ET | 1248 | 24.45 |
| 10:35 ET | 2000 | 24.46 |
| 10:37 ET | 550 | 24.46 |
| 10:39 ET | 3659 | 24.44 |
| 10:42 ET | 2200 | 24.5 |
| 10:44 ET | 1300 | 24.45 |
| 10:48 ET | 1726 | 24.44 |
| 10:50 ET | 593 | 24.45 |
| 10:51 ET | 1800 | 24.43 |
| 10:53 ET | 3381 | 24.45 |
| 10:55 ET | 1663 | 24.44 |
| 10:57 ET | 1100 | 24.425 |
| 11:00 ET | 3341 | 24.45 |
| 11:02 ET | 1192 | 24.49 |
| 11:04 ET | 1850 | 24.45 |
| 11:06 ET | 1600 | 24.47 |
| 11:08 ET | 1585 | 24.48 |
| 11:09 ET | 400 | 24.461 |
| 11:11 ET | 1499 | 24.47 |
| 11:13 ET | 2366 | 24.45 |
| 11:15 ET | 700 | 24.46 |
| 11:18 ET | 1100 | 24.46 |
| 11:20 ET | 600 | 24.48 |
| 11:22 ET | 6832 | 24.455 |
| 11:24 ET | 2307 | 24.47 |
| 11:26 ET | 400 | 24.46 |
| 11:27 ET | 1526 | 24.46 |
| 11:29 ET | 100 | 24.455 |
| 11:31 ET | 1003 | 24.42 |
| 11:33 ET | 2333 | 24.445 |
| 11:36 ET | 1407 | 24.41 |
| 11:38 ET | 1100 | 24.4 |
| 11:40 ET | 1000 | 24.405 |
| 11:42 ET | 2300 | 24.42 |
| 11:44 ET | 1310 | 24.42 |
| 11:45 ET | 1004 | 24.42 |
| 11:47 ET | 554 | 24.41 |
| 11:49 ET | 700 | 24.44 |
| 11:51 ET | 831 | 24.44 |
| 11:54 ET | 600 | 24.45 |
| 11:56 ET | 2100 | 24.465 |
| 11:58 ET | 1238 | 24.49 |
| 12:02 ET | 300 | 24.48 |
| 12:03 ET | 800 | 24.5 |
| 12:05 ET | 200 | 24.51 |
| 12:07 ET | 1666 | 24.49 |
| 12:09 ET | 1218 | 24.525 |
| 12:12 ET | 2491 | 24.52 |
| 12:14 ET | 1882 | 24.54 |
| 12:16 ET | 755 | 24.5312 |
| 12:18 ET | 2502 | 24.55 |
| 12:20 ET | 1700 | 24.52 |
| 12:21 ET | 1645 | 24.53 |
| 12:23 ET | 500 | 24.54 |
| 12:25 ET | 1500 | 24.51 |
| 12:27 ET | 1289 | 24.505 |
| 12:30 ET | 1571 | 24.53 |
| 12:32 ET | 800 | 24.53 |
| 12:34 ET | 300 | 24.54 |
| 12:36 ET | 200 | 24.55 |
| 12:38 ET | 600 | 24.56 |
| 12:39 ET | 1475 | 24.555 |
| 12:41 ET | 1100 | 24.575 |
| 12:43 ET | 2694 | 24.58 |
| 12:45 ET | 300 | 24.58 |
| 12:48 ET | 100 | 24.59 |
| 12:50 ET | 907 | 24.59 |
| 12:52 ET | 300 | 24.59 |
| 12:54 ET | 500 | 24.6 |
| 12:56 ET | 3831 | 24.58 |
| 12:57 ET | 1984 | 24.57 |
| 12:59 ET | 2622 | 24.575 |
| 01:01 ET | 285 | 24.58 |
| 01:03 ET | 14300 | 24.575 |
| 01:06 ET | 2932 | 24.545 |
| 01:08 ET | 3912 | 24.56 |
| 01:10 ET | 1447 | 24.58 |
| 01:12 ET | 3677 | 24.57 |
| 01:14 ET | 3088 | 24.56 |
| 01:15 ET | 1782 | 24.5605 |
| 01:17 ET | 1926 | 24.575 |
| 01:19 ET | 1614 | 24.58 |
| 01:21 ET | 100 | 24.59 |
| 01:24 ET | 2679 | 24.6 |
| 01:26 ET | 2010 | 24.58 |
| 01:28 ET | 2545 | 24.6 |
| 01:30 ET | 1647 | 24.59 |
| 01:32 ET | 300 | 24.59 |
| 01:33 ET | 1820 | 24.6 |
| 01:35 ET | 21225 | 24.62 |
| 01:37 ET | 1841 | 24.62 |
| 01:39 ET | 2104 | 24.645 |
| 01:42 ET | 2405 | 24.64 |
| 01:44 ET | 876 | 24.65 |
| 01:46 ET | 1000 | 24.68 |
| 01:48 ET | 1100 | 24.69 |
| 01:50 ET | 200 | 24.71 |
| 01:51 ET | 6949 | 24.71 |
| 01:53 ET | 800 | 24.71 |
| 01:55 ET | 3478 | 24.7 |
| 01:57 ET | 994 | 24.7 |
| 02:00 ET | 1300 | 24.695 |
| 02:02 ET | 2115 | 24.7 |
| 02:04 ET | 2118 | 24.715 |
| 02:06 ET | 5940 | 24.69 |
| 02:08 ET | 1500 | 24.71 |
| 02:09 ET | 1500 | 24.72 |
| 02:11 ET | 2406 | 24.71 |
| 02:13 ET | 418 | 24.73 |
| 02:15 ET | 550 | 24.73 |
| 02:18 ET | 700 | 24.735 |
| 02:20 ET | 1100 | 24.74 |
| 02:22 ET | 3355 | 24.725 |
| 02:24 ET | 2715 | 24.72 |
| 02:26 ET | 200 | 24.71 |
| 02:27 ET | 781 | 24.73 |
| 02:29 ET | 661 | 24.7199 |
| 02:31 ET | 300 | 24.71 |
| 02:33 ET | 3668 | 24.715 |
| 02:36 ET | 600 | 24.72 |
| 02:38 ET | 1044 | 24.735 |
| 02:40 ET | 500 | 24.74 |
| 02:42 ET | 830 | 24.745 |
| 02:44 ET | 544 | 24.745 |
| 02:45 ET | 1943 | 24.74 |
| 02:47 ET | 616 | 24.75 |
| 02:49 ET | 2508 | 24.74 |
| 02:51 ET | 626 | 24.76 |
| 02:54 ET | 3135 | 24.75 |
| 02:56 ET | 4154 | 24.735 |
| 02:58 ET | 2784 | 24.735 |
| 03:00 ET | 2710 | 24.76 |
| 03:02 ET | 4727 | 24.75 |
| 03:03 ET | 900 | 24.74 |
| 03:05 ET | 993 | 24.725 |
| 03:07 ET | 1140 | 24.74 |
| 03:09 ET | 1379 | 24.76 |
| 03:12 ET | 3439 | 24.72 |
| 03:14 ET | 414 | 24.7099 |
| 03:16 ET | 1700 | 24.715 |
| 03:18 ET | 230 | 24.725 |
| 03:20 ET | 2445 | 24.7193 |
| 03:21 ET | 2936 | 24.695 |
| 03:23 ET | 1710 | 24.66 |
| 03:25 ET | 6197 | 24.72 |
| 03:27 ET | 4259 | 24.665 |
| 03:30 ET | 1180 | 24.67 |
| 03:32 ET | 1440 | 24.66 |
| 03:34 ET | 35235 | 24.7 |
| 03:36 ET | 3846 | 24.68 |
| 03:38 ET | 5174 | 24.66 |
| 03:39 ET | 1600 | 24.66 |
| 03:41 ET | 1950 | 24.68 |
| 03:43 ET | 3615 | 24.665 |
| 03:45 ET | 9835 | 24.63 |
| 03:48 ET | 4493 | 24.615 |
| 03:50 ET | 2467 | 24.61 |
| 03:52 ET | 8483 | 24.655 |
| 03:54 ET | 11821 | 24.67 |
| 03:56 ET | 23313 | 24.665 |
| 03:57 ET | 21262 | 24.64 |
| 03:59 ET | 41639 | 24.68 |
Apr 24, 2024
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1, from 7:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
7:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 19, 2024
DJ Alkermes Price Target Maintained With a $35.00/Share by HC Wainwright & Co., from 6:27AM ET on Friday Apr 19, 2024 by Dow Jones
6:27AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Alkermes to Report First Quarter Financial Results on May 1, 2024, from 4:00PM ET on Wednesday Apr 17, 2024 by Dow Jones
4:00PM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 9, 2024
DJ Alkermes Is Maintained at Buy by Jefferies, from 12:17PM ET on Tuesday Apr 09, 2024 by Dow Jones
12:17PM ET on Tuesday Apr 09, 2024 by Dow JonesAlkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia, from 7:00AM ET on Tuesday Apr 09, 2024 by Dow Jones
7:00AM ET on Tuesday Apr 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Alkermes Plc | 4.2B | 8.2x | --- |
Exelixis Inc | 7.0B | 36.6x | -21.77% |
Sinovac Biotech Ltd | 639.9M | -1.8x | +15.89% |
Halozyme Therapeutics Inc | 4.9B | 18.3x | --- |
PTC Therapeutics Inc | 2.2B | -3.7x | --- |
P3 Health Partners Inc | 141.0M | -0.7x | --- |
Company Information
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Contact Information
- Headquarters
- Connaught HSE, 1 Burlington RoadDUBLIN, Ireland 00000
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Richard Pops
- Chief Financial Officer, Senior Vice President
- Iain Brown
- Chief Operating Officer, Executive Vice President
- Blair Jackson
- Executive Vice President, Chief Compliance Officer, Chief Legal Officer, Secretary
- David Gaffin
- Executive Vice President, Research and Development and Chief Medical Officer
- Craig Hopkinson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
|---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $3.02 |
Book Value | $7.20 |
P/E Ratio | 8.2x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | 7.0x |
Operating Margin | 24.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
